Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast – 2021 to 2026

$3,850.00$5,850.00

Published on: June 8, 2021
Clear
SKU: GMS-3199-1 Category:

OVERVIEW

1 INTRODUCTION

1.1 STUDY OBJECTIVES

• To forecast the market in terms of value, volume, and CAGR (2021-2026).

• To provide in-depth information pertaining to opportunities, risks, drivers, challenges and emerging trends in the market.

• To analyze the sector with respect to prospects, trends and market-influencing factors.

• To analyze emerging developments, including with respect to new products, partnerships, collaborations, mergers, expansions in the market.

• To provide insight into key players in the market and strategically analyze their market contribution with respect to revenue generation and competencies.

1.2 DEFINITION

1.3 STUDY SCOPE

1.3.1 MARKETS COVERED

This report includes the demand- and supply-side analyses of the Infectious Disease Diagnostic Market. The supply-side market segmentation includes Product & Services, Technology, Disease Type, and End User, while the demand-side segmentation includes various industries and regions.

The following diagram provides an overview of the micro markets covered in the Infectious Disease Diagnostic Market report.

Figure 1 INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION

Description: Amid the COVID-19 outbreak, the global infectious disease diagnostics market is expected to reach USD 37.4 billion by 2026, growing at a CAGR of 7.05% during the forecast period. The global prevalence of infectious diseases and the emergence of COVID-19, as well as rising awareness for early illness identification, a shift in focus from centralized laboratories to decentralized POC testing, and technical improvements, are driving market growth.

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 1

1.3.2 GEOGRAPHICSCOPE

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 2

1.3.3 YEARSCONSIDERED

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 3

1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA

This section of the report helps in understanding the methodology implemented during the development of the Infectious Disease Diagnostic Market report. There are 2 basic sources of information, which include secondary sources and primary sources that have been used to identify and collect the information for an extensive technical and commercial study of the Infectious Disease Diagnostic Market. Secondary sources include company websites, magazines, and databases (OneSource, Factiva, and Bloomberg). Primary sources mainly include several industry experts from the core and related industries, along with preferred suppliers, manufacturers, distributors, service providers, reimbursement providers, technology developers, alliances, and standards and certification organizations related to various parts of this industry’s value chain.

The key players in the Infectious Disease Diagnostic Market have been identified through secondary research, and their market share has been determined through primary and secondary research. This research includes the study of annual reports of market players to identify the top players and interview with key opinion leaders such as CEOs, directors, and marketing personnel. The following illustration depicts the market research methodology applied in making this report on the Infectious Disease Diagnostic Market.

Figure 2 INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCH DESIGN

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 4

2.1.1 SECONDARY DATA

In the secondary research process, various secondary sources have been referred to for identifying and collecting information important for this study. Secondary sources include corporate filings (such as annual reports, investor presentations, and financial statements); trade, business, and professional associations; white papers, related journals and certified publications; articles from recognized authors, gold and silver standard websites; directories; and databases.

Secondary research has been mainly used to obtain key information about the industry’s supply chain, market’s value chain, total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments from both market- and technology-oriented perspectives. The secondary data has been collected and analyzed to arrive at the overall market size, which has been further validated by primary research.

2.1.1.1 SECONDARY SOURCES

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 5

2.1.2 PRIMARY DATA

In the primary research process, various primary sources from both supply and demand sides have been interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from major companies and organizations operating in the Infectious Disease Diagnostic Market. After the complete market engineering (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research has been conducted to gather information and verify and validate the critical numbers arrived at. Primary research has been conducted to identify segmentation types, industry trends, key players, competitive landscape, and key market dynamics, namely, drivers, restraints, opportunities, challenges, and industry trends, along with key strategies adopted by market players.

Extensive primary research has been conducted after acquiring knowledge about the Infectious Disease Diagnostic Market scenario through secondary research. Several primary interviews have been conducted with market experts from both the demand and supply sides across the 4 major regions—North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW). RoW comprises the Middle East, Africa, and South America. Approximately, 60% and 40% primary interviews have been conducted with both the demand- and supply-side parties, respectively. This primary data has been collected through questionnaires, emails, and telephonic interviews.

2.1.2.1 PRIMARY SOURCES

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 6

2.1.2.2 BREAKDOWN OF PRIMARIES

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 7

2.2 MARKET SIZE ESTIMATION

In the complete market engineering process, both top-down and bottom-up approaches, along with several data triangulation methods, have been used to perform the market size estimation and forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and quantitative analyses have been performed on the complete market engineering process to list the key information/insights throughout the report.

The following table explains the process flow of the market size estimation.

Figure 3 Research Flow of Market Size Estimation

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 8

The key players in the market have been identified through secondary research, and their market shares in respective regions have been determined through primary and secondary research. This entire procedure includes the study of annual and financial reports of top players as well as extensive interviews of industry experts (such as CEOs, VPs, directors, and marketing executives) for key insights (both quantitative and qualitative) on the Infectious Disease Diagnostic Market. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data has been consolidated and supplemented with detailed inputs and analysis from Global Market Studies and presented in this report.

2.2.1 BOTTOM-UP APPROACH

The bottom-up procedure has been employed to arrive at the overall size of the Infectious Disease Diagnostic Market from revenues of key players (companies) and their share in the market. The overall market size has been calculated on the basis of the revenues of the key companies identified in the market.

Figure 4 Market Size Estimation Methodology: Bottom-Up Approach

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 9

2.2.2 TOP-DOWN APPROACH

In the top-down approach, the overall market size has been used to estimate the size of the individual markets (mentioned in the market segmentation) through percentage splits from secondary and primary researches. For the calculation of specific market segments, the most appropriate parent market size has been used to implement the top-down approach. The bottom-up approach has also been implemented for the data extracted from the secondary research to validate the market size of various segments.

The market share of each company has been estimated to verify the revenue shares used earlier in the bottom-up approach. With the data triangulation procedure and validation of data through primaries, the overall parent market size and each individual market size have been determined and confirmed in this study. The data triangulation procedure used in this study is explained in the next section.

Figure 5 Market Size Estimation Methodology: Top-Down Approach

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 10

2.2.3 MARKET SHARE ESTIMATION

The market share of manufacturing companies has been arrived at on the basis of the secondary data available through paid and unpaid sources, as well as on the basis of the analysis of product portfolios of major companies and rating them according to the performance and quality. This data has been further validated through primary sources.

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

After arriving at the overall market size from the market size estimation process explained in the earlier section, the overall Infectious Disease Diagnostic Market has been split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market has been validated using both top-down and bottom-up approaches.

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 11

2.4 RESEARCH ASSUMPTIONS

The following assumptions have been taken into consideration to complete the overall market engineering of the Infectious Disease Diagnostic Market.

Figure 7 Assumptions of Research Study

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 12

3 EXECUTIVE SUMMARY
FIGURE 8 MARKET GEOGRAPHICAL ANALYSIS, 2020& 2026

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 13

FIGURE 9 GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY SEGMENT (2020 VS 2026)

Infectious Disease Diagnostic Market By Product & Services, By Technology, By Disease Type, By End User, Geography and Forecast - 2021 to 2026 14

TABLE OF CONTENT

TABLE OF CONTENTS

1 INTRODUCTION

1.1 STUDYOBJECTIVES
1.2 DEFINITION
1.3 STUDYSCOPE
1.3.1 MARKETSCOVERED
1.3.2 GEOGRAPHICSCOPE
1.3.3 YEARSCONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS

2 RESEARCHMETHODOLOGY

2.1 RESEARCHDATA
2.1.1 SECONDARY DATA
2.1.1.1 SECONDARYSOURCES
2.1.2 PRIMARYDATA
2.1.2.1 PRIMARYSOURCES
2.1.2.2 BREAKDOWNOFPRIMARIES
2.2 MARKETSIZEESTIMATION
2.2.1 BOTTOM-UPAPPROACH
2.2.2 TOP-DOWNAPPROACH
2.2.3 MARKETSHAREESTIMATION
2.3 MARKET BREAKDOWN ANDDATATRIANGULATION
2.4 RESEARCHASSUMPTIONS
3 EXECUTIVESUMMARY

4 MARKETOVERVIEW

4.1 INTRODUCTION
4.2 MARKETDYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.2.4 CHALLENGES

5 INDUSTRYTRENDS

5.1 INTRODUCTION
5.2 VALUECHAIN

6 INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY PRODUCT & SERVICES

6.1 INTRODUCTION
6.2 Reagents, Kits, and Consumables
6.3 Instruments
6.4 Software & Services

7 INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TECHNOLOGY

7.1 INTRODUCTION
7.2 Immunodiagnostics
7.3 Clinical Microbiology
7.4 DNA Microarray
7.5 DNA sequencing and next generation sequencing
7.6 Polymerase Chain Reaction
7.7 Isothermal Nucleic Acid Amplification Technology(INAAt)
7.8 Others

8 INFECTIOUS DISEASE DIAGNOSTIC MARKET, BYDISEASE TYPE

8.1 INTRODUCTION
8.2 HIV
8.3 Hepatitis
8.4 Human Papillomavirus
8.5 COVID-19
8.6 Tuberculosis
8.7 Influenza
8.8 Other

9 INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER

9.1 INTRODUCTION
9.2 Hospital/Clinical laboratories
9.3 Reference laboratories
9.4 Others

10 GEOGRAPHIC ANALYSIS

10.1 INTRODUCTION
10.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.2.3 MEXICO
10.3 EUROPE
11.3.1 UK
11.2.4 GERMANY
11.2.5 FRANCE
11.2.6 ITALY
11.2.7 RESTOFEUROPE
11.3 ASIAPACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 SOUTHKOREA
11.4.4 INDIA
11.4.5 RESTOFAPAC
11.5 REST OF THEWORLD(ROW)
11.5.1 MIDDLEEAST
11.5.2 SOUTHAMERICA
11.5.3 AFRICA

11 MARKET ENTROPY

12.1 NEW PRODUCT LAUNCHES
12.2 M&A’s, COLLABORATIONS, JVs, AND PARTNERSHIPS

12 COMPANYPROFILES

12.1 INTRODUCTION
(Business overview, Products offered, Recent developments)*
12.2 KEYPLAYERS
12.2.1 Thermo Fisher Scientific Inc.
12.2.2 Danaher Corporation
12.2.3 Abbott Laboratories
12.2.4 Siemens Healthineers AG
12.2.5 Becton, Dickinson and Company
12.2.6 F. Hoffmann-La Roche Ltd
12.2.7 BioMérieux SA
12.2.8 Quidel Corporation
12.2.9 Hologic, Inc.
12.2.10 PerkinElmer Inc.
12.2.11 Company 11 & More
*Details on Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.

13 APPENDIX

13.1 SOURCES
13.2 ABBREVIATIONS